This central nervous system mechanism distinguishes PT-141 from peripheral vascular approaches to sexual function research, making it relevant in studies examining neurological pathways of sexual motivation
Previous studies in rats and small clinical trials involving children with ASD suggest that the drug bumetanide, which has been approved for use in oedema, a condition that results in a build-up of fluid in the body, could help reduce symptoms of ASD
Intravenous Administration: Delivered directly into the bloodstream, this method is typically used for individuals with certain conditions, such as diabetes or Parkinsons disease
However, in the face of chronic, complex illness, this vital defense mechanism can become profoundly overwhelmed and depleted
doi: 10.1046/j.1463-1326.1999.00028.x 136 RainsJLJainSK
Thats why generic availability is such a closely watched topic